LU75513A1 - - Google Patents

Info

Publication number
LU75513A1
LU75513A1 LU75513A LU75513A LU75513A1 LU 75513 A1 LU75513 A1 LU 75513A1 LU 75513 A LU75513 A LU 75513A LU 75513 A LU75513 A LU 75513A LU 75513 A1 LU75513 A1 LU 75513A1
Authority
LU
Luxembourg
Application number
LU75513A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75513A1 publication Critical patent/LU75513A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU75513A 1975-07-31 1976-07-30 LU75513A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3200575 1975-07-31
GB3200475 1975-07-31
GB2718476 1976-06-30

Publications (1)

Publication Number Publication Date
LU75513A1 true LU75513A1 (cg-RX-API-DMAC7.html) 1977-04-15

Family

ID=27258606

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75513A LU75513A1 (cg-RX-API-DMAC7.html) 1975-07-31 1976-07-30

Country Status (10)

Country Link
JP (1) JPS5218831A (cg-RX-API-DMAC7.html)
AU (1) AU1643776A (cg-RX-API-DMAC7.html)
DE (1) DE2634409A1 (cg-RX-API-DMAC7.html)
DK (1) DK345676A (cg-RX-API-DMAC7.html)
FR (1) FR2319346A1 (cg-RX-API-DMAC7.html)
IL (1) IL50174A0 (cg-RX-API-DMAC7.html)
LU (1) LU75513A1 (cg-RX-API-DMAC7.html)
NL (1) NL7608503A (cg-RX-API-DMAC7.html)
NZ (1) NZ181635A (cg-RX-API-DMAC7.html)
SE (1) SE7608611L (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
IT1194677B (it) * 1980-08-05 1988-09-22 Italfarmaco Spa Composizione farmaceutica ad attivita' antiflogistica,antipiretica e antalgica
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US5164406A (en) * 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition

Also Published As

Publication number Publication date
IL50174A0 (en) 1976-09-30
SE7608611L (sv) 1977-02-01
DK345676A (da) 1977-02-01
FR2319346A1 (fr) 1977-02-25
AU1643776A (en) 1978-02-02
FR2319346B1 (cg-RX-API-DMAC7.html) 1979-05-25
JPS5218831A (en) 1977-02-12
DE2634409A1 (de) 1977-02-17
NZ181635A (en) 1978-09-25
NL7608503A (nl) 1977-02-02

Similar Documents

Publication Publication Date Title
FR2319346B1 (cg-RX-API-DMAC7.html)
JPS5236321U (cg-RX-API-DMAC7.html)
JPS5257593U (cg-RX-API-DMAC7.html)
JPS5198007A (cg-RX-API-DMAC7.html)
JPS5444386Y2 (cg-RX-API-DMAC7.html)
JPS5211082Y2 (cg-RX-API-DMAC7.html)
JPS5648545B2 (cg-RX-API-DMAC7.html)
JPS5717458B2 (cg-RX-API-DMAC7.html)
JPS5194420U (cg-RX-API-DMAC7.html)
JPS5278965U (cg-RX-API-DMAC7.html)
JPS5286926U (cg-RX-API-DMAC7.html)
CS178241B1 (cg-RX-API-DMAC7.html)
CH597750A5 (cg-RX-API-DMAC7.html)
BG21530A1 (cg-RX-API-DMAC7.html)
CH599019A5 (cg-RX-API-DMAC7.html)
CH596331A5 (cg-RX-API-DMAC7.html)
CH599497A5 (cg-RX-API-DMAC7.html)
CH576092A5 (cg-RX-API-DMAC7.html)
CH600083A5 (cg-RX-API-DMAC7.html)
CH599384A5 (cg-RX-API-DMAC7.html)
BG21450A1 (cg-RX-API-DMAC7.html)
CH596119A5 (cg-RX-API-DMAC7.html)
CH605665A5 (cg-RX-API-DMAC7.html)
BG22893A1 (cg-RX-API-DMAC7.html)
CH593408A5 (cg-RX-API-DMAC7.html)